English
Specials
Go Ad-Free
My Alerts
Moneycontrol
Moneycontrol PRO
Get App Open
In App
Lending
Lending
Go PRO Now
Open App
you are here:
MARKETS

Sun Pharma Advanced Research Company Ltd.

BSE: 532872 | NSE: SPARC |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE232I01014 | SECTOR: Biotechnology & Medical Research

| BSE 129.05 1.00 (0.78%) | |

BSE Live

Oct 09, 16:01
129.05 1.00 (0.78%)
Volume
AVERAGE VOLUME
5-Day
18,910
10-Day
21,076
30-Day
21,286
24,863

  • Prev. Close

    128.05

  • Open Price

    128.15

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    0.00 (0)

NSE Live

Oct 09, 15:59
128.03 -0.02 (-0.02%)
Volume
AVERAGE VOLUME
5-Day
198,789
10-Day
222,313
30-Day
221,775
314,469

  • Prev. Close

    128.05

  • Open Price

    128.05

  • Bid Price (Qty.)

    128.03 (2020)

  • Offer Price (Qty.)

    0.00 (0)

Financials

Cash Flow of Sun Pharma Advanced Research Company (in Rs. Cr.) Mar 25 Mar 24 Mar 23  
  12 mths 12 mths 12 mths  
Net Profit/Loss Before Extraordinary Items And Tax -342.78 -386.83 -222.58  
Net CashFlow From Operating Activities -360.29 -429.19 -69.12  
Net Cash Used In Investing Activities 157.66 391.53 -548.28  
Net Cash Used From Financing Activities 199.26 42.41 616.76  
Foreign Exchange Gains / Losses 0.01 0.00 0.00  
Adjustments On Amalgamation Merger Demerger Others 0.00 0.00 0.00  
Net Inc/Dec In Cash And Cash Equivalents -3.37 4.75 -0.64  
Cash And Cash Equivalents Begin of Year 5.33 0.58 1.22  
Cash And Cash Equivalents End Of Year 1.96 5.33 0.58  
Source : Dion Global Solutions Limited

Results of Sun Pharma Adv

  • 01.01.1970

  • 01.01.1970

Results of Pharmaceuticals Sector

Quick links

News

Corporate Action

Information

Financials

Annual Report

Peer Comparison

Related Searches

Sun Pharma Advanced Research Company Stock Price | Sun Pharma Adv Stock Quote | Sun Pharma Adv Results | Sun Pharma Adv News | View All Related Searches
Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347